Bio Briefs
Posted By
Recent Posts on This Topic | See All >
-
Feb 07, 2012 Support grows for medical-device community -
Dec 19, 2011 BioAccel launches network to attract bio funding
-
Jul 19, 2011 Cardinal Health opens $11M Phoenix facility
-
Apr 07, 2011 Algae Biosciences Corp. taken public
Share on Twitter
Share on Facebook
Email to a friend
Print Article
UA spinoff gets $3M for valley fever work
[Source: Arizona Daily Star] - A drug company spun off by University of Arizona researchers has been awarded $3 million by the National Institutes of Health to continue development of a cure for valley fever, which sickens 150,000 people yearly, two-thirds of them in Arizona.
Valley Fever Solutions Inc. is an outgrowth of the UA's Valley Fever Center for Excellence. It was created in 2008, in part to gain regulatory approval for nikkomycin Z, or Nik Z, a promising cure for the ailment.
Dr. John Galgiani, director of the center and chief medical officer for the company, said the money will be used over the next year to begin producing the drug with a new process that should make it more economical.
For more information: UA spinoff gets $3M for valley fever work
Quick Links
- NEW: About the Arizona Center for Civic Leadership
- Arizona Biosciences News
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Arizona BioBasics
- The Biozona Brand
- Newsletter Signup
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.
